Point72 Asset Management’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.17M | Sell |
|
|||||
|
2025
Q1 | $16M | Buy |
|
|||||
|
2024
Q4 | $21.8M | Buy |
|
|||||
|
2024
Q3 | $3.68M | Sell |
|
|||||
|
2024
Q2 | $12.6M | Sell |
|
|||||
|
2024
Q1 | $19.5M | Buy |
|
|||||
|
2023
Q4 | $5.18M | Sell |
|
|||||
|
2023
Q3 | $5.16M | Buy |
|
|||||
|
2023
Q2 | $4.82M | Sell |
|
|||||
|
2023
Q1 | $10.6M | Sell |
|
|||||
|
2022
Q4 | $16.1M | Sell |
|
|||||
|
2022
Q3 | $19M | Buy |
|
|||||
|
2022
Q2 | $9.39M | Sell |
|
|||||
|
2022
Q1 | $18.2M | Buy |
|
|||||
|
2021
Q4 | $14.9M | Buy |
|
|||||
|
2021
Q3 | $13.4M | Buy |
|
|||||
|
2021
Q2 | $14.3M | Buy |
|
|||||
|
2021
Q1 | $5.48M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $404K | Buy |
|